← Back to Search

Asthma Management App for Asthma (PEAKmAAP Trial)

Q: How many individuals are contributing to the data of this research project?

Affirmative. Clinicaltrials.gov has information suggesting that this medical research is actively seeking participants to enroll, with the first posting of the trial occuring on March 4th 2019 and most recent update occurring on January 3rd 2022. The study requires 372 individuals from a single location to participate in it.

Q: Is enrollment for this research endeavor still open?

Affirmative. The information found on clinicaltrials.gov reveals that this medical trial, which commenced its recruitment efforts on March 4th 2019, is still actively seeking participants. A total of 372 patients need to be recruited from one location.

Q: Are elderly patients being sought for this experiment?

The enrolment requirements for this medical trial are for those between the ages of 12 and 20. 116 studies exist to research patients younger than 18, while 198 trials cover elderly citizens over 65 years old.

Q: Who meets the criteria to partake in this research experiment?

This research trial seeks 372 participants aged 12 to 20 who suffer from <a href="https://www.withpower.com/clinical-trials/asthma">asthma</a>. In addition, the applicants must have an Asthma Control Test (ACT) score of 19 or lower, access to a compatible smartphone with PEAKmAAP and NutriMap applications installed, as well as internet connectivity.

N/A

Waitlist Available

Led By Tamara T. Perry, MD

Research Sponsored by Arkansas Children's Hospital Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥12 and <21 years

Persistent asthma according to national guidelines criteria

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

PEAKmAAP Trial Summary

This trial will test how well an app helps manage asthma for 372 adolescents and young adults.

Who is the study for?

This trial is for adolescents and young adults aged 12 to under 21 with persistent asthma, as defined by national guidelines. They must have an ACT score of 19 or less, been prescribed asthma controller medication in the last six months, and have access to a smartphone and internet. It's not for those with other significant respiratory diseases besides asthma, severe co-morbid conditions that could affect self-monitoring, participants in recent clinical trials on asthma, or current smokers.Check my eligibility

What is being tested?

The study tests a mobile app designed to help manage asthma more effectively among high-risk patients. The app is based on the traditional written asthma action plan but optimized for smartphones. Participants will be divided into groups: one using the standard care NutriMap app and others using different versions of the PEAKmAAP app.See study design

What are the potential side effects?

Since this trial involves using an m-health intervention rather than medication, there are no direct physical side effects like you'd expect from drugs. However, users might experience stress or frustration if they encounter technical issues with the app.

PEAKmAAP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 12 and 20 years old.

Select...

I have been diagnosed with long-term asthma.

Select...

I have been on asthma control medication in the last 6 months.

PEAKmAAP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Asthma Control Test (ACT) Score

Composite Asthma Severity Index (CASI) score

Healthcare Utilization

Secondary outcome measures

Mediators of Asthma Control

PEAKmAAP Trial Design

3Treatment groups

Experimental Treatment

Group I: PEAKmAAP-Data Sharing (DS)Experimental Treatment1 Intervention

PEAKmAAP with Data Sharing (PEAKmAAP-DS) group will be asked to enter asthma symptoms or peak flow every day. The PEAKmAAP guides participants when to take asthma medicines and sends reminders to take their medicines every day. PEAKmAAP also provides reminders when to get asthma medicines refilled. Asthma education messages and video links are also pushed via notification. The primary care provided (PCP) will receive monthly reports to help them know how the participant's asthma symptoms are over time.

Group II: PEAKmAAPExperimental Treatment1 Intervention

The Pulmonary Education and Asthma Knowledge mobile asthma action plan (PEAKmAAP) group will use a mobile "app" that will help manage asthma. Participants will be asked to enter asthma symptoms or peak flow every day. The PEAKmAAP guides participants when to take asthma medicines and sends reminders to take their medicines every day. mAAP also provides reminders when to get asthma medicines refilled. Asthma education messages and video links are also pushed via notification.

Group III: Nutrition Map (NutriMap) Usual CareExperimental Treatment1 Intervention

Participants in this arm will use a smartphone application that sends daily non-asthma-related reminder for attention control. Participants will be asked to log their daily fruits and vegetables eaten. Participants will answer survey questions about their asthma and symptoms management.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Arkansas Children's Hospital Research InstituteLead Sponsor

135 Previous Clinical Trials

5,028,995 Total Patients Enrolled

13 Trials studying Asthma

2,829 Patients Enrolled for Asthma

Tamara T. Perry, MDPrincipal InvestigatorUniversity of Arkansas

2 Previous Clinical Trials

38 Total Patients Enrolled

2 Trials studying Asthma

38 Patients Enrolled for Asthma

Media Library

NutriMap Usual Care Clinical Trial Eligibility Overview. Trial Name: NCT03842033 — N/A

Asthma Research Study Groups: PEAKmAAP-Data Sharing (DS), PEAKmAAP, Nutrition Map (NutriMap) Usual Care

Asthma Clinical Trial 2023: NutriMap Usual Care Highlights & Side Effects. Trial Name: NCT03842033 — N/A

NutriMap Usual Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT03842033 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are contributing to the data of this research project?

"Affirmative. Clinicaltrials.gov has information suggesting that this medical research is actively seeking participants to enroll, with the first posting of the trial occuring on March 4th 2019 and most recent update occurring on January 3rd 2022. The study requires 372 individuals from a single location to participate in it."

Answered by AI

Is enrollment for this research endeavor still open?

"Affirmative. The information found on clinicaltrials.gov reveals that this medical trial, which commenced its recruitment efforts on March 4th 2019, is still actively seeking participants. A total of 372 patients need to be recruited from one location."

Answered by AI

Are elderly patients being sought for this experiment?

"The enrolment requirements for this medical trial are for those between the ages of 12 and 20. 116 studies exist to research patients younger than 18, while 198 trials cover elderly citizens over 65 years old."

Answered by AI

Who meets the criteria to partake in this research experiment?

"This research trial seeks 372 participants aged 12 to 20 who suffer from asthma. In addition, the applicants must have an Asthma Control Test (ACT) score of 19 or lower, access to a compatible smartphone with PEAKmAAP and NutriMap applications installed, as well as internet connectivity."

Answered by AI

Recent research and studies

Journal of Allergy and Clinical ImmunologyJournal

Adolescents and Asthma: Why Bother with Our Meds?

Naimi, David R., Tovia G. Freedman, Kenneth R. Ginsburg, Daniel Bogen, Cynthia S. Rand, and Andrea J. Apter. 2009. “Adolescents and Asthma: Why Bother with Our Meds?”. Journal of Allergy and Clinical Immunology. Elsevier BV. doi:10.1016/j.jaci.2009.02.022.

formation/NLM/NIH, NCBI. “Gprobe”. 2017. Web. <https://github.com/ncbi/gprobe>..Journal

Gprobe

Information/NLM/NIH, NCBI. 2017. “Gprobe”. GitHub repository. https://github.com/ncbi/gprobe.

Respiratory MedicineJournal

Practical Evaluation of Asthma Exacerbation Self-management in Children and Adolescents

RAHERISON, C., J.M. TUNON-DE-LARA, J.M. VERNEJOUX, and A. TAYTARD. 2000. “Practical Evaluation of Asthma Exacerbation Self-management in Children and Adolescents”. Respiratory Medicine. Elsevier BV. doi:10.1053/rmed.2000.0888.

Journal of Adolescent HealthJournal